홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

Glycine → HCID 178491777, 화합물

HRID 1827259
인쇄

반응식

HRID 1827259 반응식
[NH:1]([C:63]([O:65][CH2:66][CH:67]1[C:79]2[C:74](=[CH:75][CH:76]=[CH:77][CH:78]=2)[C:73]2[C:68]1=[CH:69][CH:70]=[CH:71][CH:72]=2)=[O:64])[C@H:2]([C:24]([NH:26][CH2:27][C:28]([NH:30][C@H:31]([C:40]([NH:42][C@@H:43]([C:51]([N:53]([CH3:62])[C@H:54]([C:58]([O:60][Na])=[O:59])[CH:55]([CH3:57])[CH3:56])=[O:52])[CH2:44][C:45]1[CH:50]=[CH:49][CH:48]=[CH:47][CH:46]=1)=[O:41])[CH2:32][C:33](=[O:39])[O:34][C:35]([CH3:38])([CH3:37])[CH3:36])=[O:29])=[O:25])[CH2:3][CH2:4][CH2:5][NH:6][C:7](=[NH:23])[NH:8][S:9]([C:12]1[C:21]([CH3:22])=[C:19]([CH3:20])[C:16]([O:17][CH3:18])=[CH:15][C:13]=1[CH3:14])(=[O:11])=[O:10].N(C)[C@H](C(O)=O)C(C)C.N[C@@H](C(O)=O)CC1C=CC=CC=1.N[C@H](C(O)=O)CC(=O)OC(C)(C)C.NCC(O)=O.N(C(OCC1C2C(=CC=CC=2)C2C1=CC=CC=2)=O)[C@H](C(O)=O)CCCNC(=N)NS(C1C(C)=C(C)C(OC)=CC=1C)(=O)=O.C(O)(C(F)(F)F)=O.ClCCl>>[NH:1]([C:63]([O:65][CH2:66][CH:67]1[C:79]2[C:74](=[CH:75][CH:76]=[CH:77][CH:78]=2)[C:73]2[C:68]1=[CH:69][CH:70]=[CH:71][CH:72]=2)=[O:64])[C@H:2]([C:24]([NH:26][CH2:27][C:28]([NH:30][C@H:31]([C:40]([NH:42][C@@H:43]([C:51]([N:53]([CH3:62])[C@H:54]([C:58]([OH:60])=[O:59])[CH:55]([CH3:56])[CH3:57])=[O:52])[CH2:44][C:45]1[CH:50]=[CH:49][CH:48]=[CH:47][CH:46]=1)=[O:41])[CH2:32][C:33](=[O:39])[O:34][C:35]([CH3:38])([CH3:36])[CH3:37])=[O:29])=[O:25])[CH2:3][CH2:4][CH2:5][NH:6][C:7](=[NH:23])[NH:8][S:9]([C:12]1[C:21]([CH3:22])=[C:19]([CH3:20])[C:16]([O:17][CH3:18])=[CH:15][C:13]=1[CH3:14])(=[O:11])=[O:10]
참가 물질실험 절차출처 및 근거반응 노트

참가 물질

8

반응물 7

HCID 750GlycineHCID 71567D-PhenylalanineHCID 444080N-Methyl-L-valineHCID 70105704-tert-Butyl hydrogen L-aspartateHCID 21863450Trifluoroacetic acid methylene chlorideHCID 178491778HCID 178491778, 화합물
HCID 178491779
HCID 178491779, 화합물

생성물 1

HCID 178491777HCID 178491777, 화합물

실험 절차

Fmoc-Arg(Mtr)-Gly-Asp(OBut)-DPhe-NMeVal-ONa (SEQ ID NO 41) is synthesized using solid-phase Merrifield-type procedures by sequentially adding NMeVal, DPhe, Asp(OBut), Gly and Fmoc-Arg(Mtr) in a step-wise manner to a 4-hydroxymethyl-phenoxymethyl-polystyrene resin (Wang type resin) (customary Merrifield-type methods of peptide synthesis are applied as described in Houben-Weyl, l.c., Volume 15/II, Pages 1 to 806 (1974). The polystyrene resin and amino acid residues precursors are commercially available from Aldrich, Sigma or Fluka chemical companies). After completion of sequential addition of the amino acid residues, the resin is then eliminated from the peptide chain using a 1:1 mixture of TFA/dichloromethane which provides the Fmoc-Arg(Mtr)-Gly-Asp(OBut)-DPhe-NMeVal-OH product (SEQ ID NO 42). The Fmoc group is then removed with a 1:1 mixture of piperidine/DMF which provides the crude Arg(Mtr)-Gly-Asp(OBut)-DPhe-NMeVal-OH (SEQ ID NO 43) precursor which is then purified by HPLC in the customary manner.

출처 및 근거

ORD 기록
ord-8a1f3e9205a64558bb261b5185b2c6ca
출처 데이터셋
uspto-grants-2006_05
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US07053041B1

반응 노트

이 페이지에서참가 물질실험 절차출처 및 근거반응 노트